Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid nano-crystals to transport a diverse array of therapeutic agents, including small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$1.32 | -$3.15 | Miss |
| May 8, 2026 | -$19.76 | -$0.30 | Beat |
| Mar 31, 2026 | -$0.78 | -$0.26 | Beat |
| Nov 10, 2025 | -$1.06 | -$0.40 | Beat |
| Aug 14, 2025 | -$1.25 | -$1.03 | Beat |
| May 15, 2025 | -$1.50 | -$0.33 | Beat |